Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A08536 | 32069337 | PLoS One | Validation of a hierarchical algorithm to define chronic liver disease and cirrhosis etiology in administrative healthcare data. | 2020 | Details |
| A08538 | 32068703 | Nursing | Nonalcoholic fatty liver disease: What nurses need to know. | 2020 | Details |
| A08539 | 32068025 | Gastroenterology | Toward Genetic Prediction of Nonalcoholic Fatty Liver Disease Trajectories: PNPLA3 and Beyond. | 2020 | Details |
| A08540 | 32068022 | Gastroenterology | Metabolic Inflammation-A Role for Hepatic Inflammatory Pathways as Drivers of Comorbidities in Nonalcoholic Fatty Liver Disease? | 2020 | Details |
| A08541 | 32067588 | J Am Heart Assoc | Longitudinal Association of Non-Alcoholic Fatty Liver Disease With Changes in Myocardial Structure and Function: The CARDIA Study. | 2020 | Details |
| A08542 | 32067271 | Phytother Res | Effects of green tea or green tea catechin on liver enzymes in healthy individuals and people with nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized clinical trials. | 2020 | Details |
| A08543 | 32066993 | Frontline Gastroenterol | The Development and Implementation of a Commissioned Pathway for the Identification and Stratification of Liver Disease in the Community. | 2019 | Details |
| A08544 | 32066758 | Sci Rep | A Microbial Signature Identifies Advanced Fibrosis in Patients with Chronic Liver Disease Mainly Due to NAFLD. | 2020 | Details |
| A08545 | 32066623 | Gut | Advances in non-invasive assessment of hepatic fibrosis. | 2020 | Details |
| A08546 | 32066395 | BMC Nephrol | Noninvasive indices for predicting nonalcoholic fatty liver disease in patients with chronic kidney disease. | 2020 | Details |
| A08547 | 32066210 | Gut Liver | Hepatic Steatosis Index in the Detection of Fatty Liver in Patients with Chronic Hepatitis B Receiving Antiviral Therapy. | 2021 | Details |
| A08548 | 32065376 | Adv Ther | Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review. | 2020 | Details |
| A08549 | 32064966 | Expert Rev Gastroenterol Hepatol | Sarcopenia in nonalcoholic fatty liver disease: new challenges for clinical practice. | 2020 | Details |
| A08551 | 32064187 | Cureus | Ketogenic Diet-induced Elevated Cholesterol, Elevated Liver Enzymes and Potential Non-alcoholic Fatty Liver Disease. | 2020 | Details |
| A08552 | 32063885 | Front Endocrinol (Lausanne) | Bone Turnover Markers and Probable Advanced Nonalcoholic Fatty Liver Disease in Middle-Aged and Elderly Men and Postmenopausal Women With Type 2 Diabetes. | 2020 | Details |
| A08553 | 32063504 | Ann Hepatol | Prevalence of liver fibrosis in an unselected general population with high prevalence of obesity and diabetes mellitus. Time for screening? | 2020 | Details |
| A08554 | 32063360 | Biochem Biophys Res Commun | Hepatic CD147 knockout modulates liver steatosis and up-regulates autophagy in high-fat-diet-induced NAFLD mice. | 2020 | Details |
| A08555 | 32062620 | J Toxicol Sci | Taurine attenuates hepatic steatosis in a genetic model of fatty liver disease. | 2020 | Details |
| A08556 | 32062042 | Clin Gastroenterol Hepatol | Development and Validation of a Scoring System, Based on Genetic and Clinical Factors, to Determine Risk of Steatohepatitis in Asian Patients with Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A08557 | 32061907 | Metabolism | Established and emerging factors affecting the progression of nonalcoholic fatty liver disease. | 2020 | Details |
| A08558 | 32061598 | Gastroenterology | Adipose Tissue-Liver Cross Talk in the Control of Whole-Body Metabolism: Implications in Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A08559 | 32061597 | Gastroenterology | Circadian Rhythms in the Pathogenesis and Treatment of Fatty Liver Disease. | 2020 | Details |
| A08560 | 32061596 | Gastroenterology | Therapeutic Landscape for NAFLD in 2020. | 2020 | Details |
| A08561 | 32061595 | Gastroenterology | Nonalcoholic Fatty Liver Disease 2020: The State of the Disease. | 2020 | Details |
| A08562 | 32061583 | Obes Res Clin Pract | Elevated 1-h post-load plasma glucose levels in normal glucose tolerance children with obesity is associated with early carotid atherosclerosis. | 2020 | Details |
| A08563 | 32061473 | Ann Hepatol | Chemotherapy-associated steatohepatitis. | 2020 | Details |
| A08564 | 32060386 | Sci Rep | Multiparametric MR Index for the Diagnosis of Non-Alcoholic Steatohepatitis in Patients with Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A08566 | 32059982 | J Hepatol | NAFLD as a driver of chronic kidney disease. | 2020 | Details |
| A08567 | 32058943 | EBioMedicine | Mboat7 down-regulation by hyper-insulinemia induces fat accumulation in hepatocytes. | 2020 | Details |
| A08568 | 32058217 | Biomed Pharmacother | Iridoids of Valeriana fauriei contribute to alleviating hepatic steatosis in obese mice by lipophagy. | 2020 | Details |
| A08569 | 32058041 | J Proteomics | Proteomic analysis to identify differentially expressed proteins between subjects with metabolic healthy obesity and non-alcoholic fatty liver disease. | 2020 | Details |
| A08570 | 32057899 | Life Sci | The regulation of TFEB in lipid homeostasis of non-alcoholic fatty liver disease: Molecular mechanism and promising therapeutic targets. | 2020 | Details |
| A08571 | 32057700 | Ann Hepatol | Role of CD98 in liver disease. | 2020 | Details |
| A08572 | 32055946 | Eur Radiol | Assessment of liver fibrosis severity using computed tomography-based liver and spleen volumetric indices in patients with chronic liver disease. | 2020 | Details |
| A08573 | 32055233 | Int J Mass Spectrom | Proteome Dynamics from Heavy Water Metabolic Labeling and Peptide Tandem Mass Spectrometry. | 2019 | Details |
| A08574 | 32054943 | Sci Rep | Bergamot Polyphenols Improve Dyslipidemia and Pathophysiological Features in a Mouse Model of Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A08575 | 32054840 | Cell Death Dis | Antagonizing circRNA_002581-miR-122-CPEB1 axis alleviates NASH through restoring PTEN-AMPK-mTOR pathway regulated autophagy. | 2020 | Details |
| A08576 | 32054543 | Br J Nutr | Combined effect of n-3 fatty acids and phytosterol esters on alleviating hepatic steatosis in non-alcoholic fatty liver disease subjects: a double-blind placebo-controlled clinical trial. | 2020 | Details |
| A08577 | 32054379 | J Recept Signal Transduct Res | Inevitable role of TGF-β1 in progression of nonalcoholic fatty liver disease. | 2020 | Details |
| A08578 | 32054087 | Int J Mol Sci | In Steatotic Cells, ATP-Citrate Lyase mRNA Is Efficiently Translated through a Cap-Independent Mechanism, Contributing to the Stimulation of De Novo Lipogenesis. | 2020 | Details |
| A08579 | 32053840 | Horm Metab Res | Phytoestrogens in NAFLD: Potential Mechanisms of Action. | 2020 | Details |
| A08580 | 32053033 | Expert Opin Ther Targets | Emerging therapeutic targets for NASH: key innovations at the preclinical level. | 2020 | Details |
| A08581 | 32052857 | Hepatology | New Drugs for NASH and HIV Infection: Great Expectations for a Great Need. | 2020 | Details |
| A08582 | 32051820 | Can J Gastroenterol Hepatol | Natural History of Nonalcoholic Fatty Liver Disease: Implications for Clinical Practice and an Individualized Approach. | 2020 | Details |
| A08583 | 32051143 | J Biol Chem | Vitamin D receptor targets hepatocyte nuclear factor 4α and mediates protective effects of vitamin D in nonalcoholic fatty liver disease. | 2020 | Details |
| A08584 | 32051092 | Eur J Intern Med | NAFLD and autoimmune hepatitis: Do not judge a book by its cover. | 2020 | Details |
| A08585 | 32050765 | J Agric Food Chem | Theaflavin TF3 Relieves Hepatocyte Lipid Deposition through Activating an AMPK Signaling Pathway by targeting Plasma Kallikrein. | 2020 | Details |
| A08586 | 32049638 | BMJ Open Diabetes Res Care | Insulin resistance, beta-cell function, adipokine profiles and cardiometabolic risk factors among Chinese youth with isolated impaired fasting glucose versus impaired glucose tolerance: the BCAMS study. | 2020 | Details |
| A08587 | 32049637 | BMJ Open Diabetes Res Care | Screening for non-alcoholic fatty liver disease in type 2 diabetes using non-invasive scores and association with diabetic complications. | 2020 | Details |
| A08588 | 32048436 | Obes Rev | Foetal and childhood exposure to famine and the risks of cardiometabolic conditions in adulthood: A systematic review and meta-analysis of observational studies. | 2020 | Details |
| A08589 | 32048317 | J Gastroenterol Hepatol | Nonalcoholic fatty liver disease burden: Australia, 2019-2030. | 2020 | Details |
| A08590 | 32048152 | Obes Surg | Alterations in the Liver Fat Fraction Features Examined by Magnetic Resonance Imaging Following Bariatric Surgery: a Self-Controlled Observational Study. | 2020 | Details |
| A08591 | 32047809 | Biomed Res Int | Recombinant Lactococcus lactis Expressing Ling Zhi 8 Protein Ameliorates Nonalcoholic Fatty Liver and Early Atherogenesis in Cholesterol-Fed Rabbits. | 2020 | Details |
| A08592 | 32046285 | Biomedicines | NAFLD Preclinical Models: More than a Handful, Less of a Concern? | 2020 | Details |
| A08593 | 32046101 | Int J Mol Sci | Adaptation of Mitochondrial Substrate Flux in a Mouse Model of Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A08594 | 32045698 | Biochim Biophys Acta Mol Cell Biol Lipids | Imbalanced insulin substrate-1 and insulin substrate-2 signaling trigger hepatic steatosis in vitamin D deficient rats: 8-methoxypsoralen, a vitamin D receptor ligand with a promising anti-steatotic action. | 2020 | Details |
| A08595 | 32045667 | Pharmacol Res | Human antigen R: A potential therapeutic target for liver diseases. | 2020 | Details |
| A08596 | 32045588 | Toxicol Appl Pharmacol | Orlistat delays hepatocarcinogenesis in mice with hepatic co-activation of AKT and c-Met. | 2020 | Details |
| A08597 | 32045507 | Mol Nutr Food Res | Lactose, Maltose, and Sucrose in Health and Disease. | 2020 | Details |
| A08598 | 32044884 | Appl Immunohistochem Mol Morphol | Novel Interplay Between Sonic Hedgehog and Transforming Growth Factor-β1 in Human Nonalcoholic Steatohepatitis. | 2020 | Details |
| A08599 | 32044821 | Eur J Gastroenterol Hepatol | Non-alcoholic fatty liver disease in inflammatory bowel disease patients. | 2020 | Details |
| A08600 | 32044522 | Biomaterials | Efficacy of primary liver organoid culture from different stages of non-alcoholic steatohepatitis (NASH) mouse model. | 2020 | Details |
| A08601 | 32044317 | Gastroenterology | Nonalcoholic Fatty Liver Disease: Modulating Gut Microbiota to Improve Severity? | 2020 | Details |
| A08602 | 32044315 | Gastroenterology | Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis. | 2020 | Details |
| A08603 | 32044314 | Gastroenterology | MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease. | 2020 | Details |
| A08604 | 32044284 | Clin Res Hepatol Gastroenterol | Does adipose tissue inflammation drive the development of non-alcoholic fatty liver disease in obesity? | 2020 | Details |
| A08605 | 32043752 | Liver Int | Metabolic regulation of hepatic PNPLA3 expression and severity of liver fibrosis in patients with NASH. | 2020 | Details |
| A08606 | 32043636 | FASEB J | REDD1 deficiency protects against nonalcoholic hepatic steatosis induced by high-fat diet. | 2020 | Details |
| A08607 | 32043613 | Hepatology | Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of NAFLD. | 2020 | Details |
| A08609 | 32043602 | Aliment Pharmacol Ther | Advanced fibrosis is associated with incident cardiovascular disease in patients with non-alcoholic fatty liver disease. | 2020 | Details |
| A08611 | 32042452 | Curr Health Sci J | Before and After Treatment Quantitative Assessment of Hepatic Steatosis in a Romanian Population Using Magnetic Resonance Liver Spectroscopy. | 2019 | Details |
| A08612 | 32042299 | Nutr Metab (Lond) | LncRNA Gm12664-001 ameliorates nonalcoholic fatty liver through modulating miR-295-5p and CAV1 expression. | 2020 | Details |
| A08613 | 32042044 | Nat Commun | Fasting-induced FGF21 signaling activates hepatic autophagy and lipid degradation via JMJD3 histone demethylase. | 2020 | Details |
| A08614 | 32041532 | BMC Gastroenterol | Non-alcoholic fatty liver disease among patients with sleep disorders: a Nationwide study of Taiwan. | 2020 | Details |
| A08615 | 32041289 | Diagnostics (Basel) | Effect of Sodium Glucose Cotransporter 2 Inhibitors on Renal Function in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes in Japan. | 2020 | Details |
| A08616 | 32040895 | Klin Lab Diagn | [The Diagnostic Importance of Circulating MicroRNA for Non-Alcoholic Fatty Liver Disease (review of literature).] | 2019 | Details |
| A08617 | 32040876 | Lipids | Gut microbial fatty acid metabolites (KetoA and KetoC) affect the progression of nonalcoholic steatohepatitis and reverse cholesterol transport metabolism in mouse model. | 2020 | Details |
| A08619 | 32039405 | JHEP Rep | A blocking monoclonal antibody to CCL24 alleviates liver fibrosis and inflammation in experimental models of liver damage. | 2020 | Details |
| A08620 | 32039399 | JHEP Rep | Lifestyle modification in NAFLD/NASH: Facts and figures. | 2019 | Details |
| A08621 | 32039397 | JHEP Rep | Platelets in chronic liver disease, from bench to bedside. | 2019 | Details |
| A08622 | 32039394 | JHEP Rep | Endoscopic duodenal mucosal resurfacing improves glycaemic and hepatic indices in type 2 diabetes: 6-month multicentre results. | 2019 | Details |
| A08623 | 32039393 | JHEP Rep | Pcsk9 knockout exacerbates diet-induced non-alcoholic steatohepatitis, fibrosis and liver injury in mice. | 2019 | Details |
| A08624 | 32039383 | JHEP Rep | Non-alcoholic fatty liver disease in lean individuals. | 2019 | Details |
| A08625 | 32039382 | JHEP Rep | From NASH to diabetes and from diabetes to NASH: Mechanisms and treatment options. | 2019 | Details |
| A08626 | 32039376 | JHEP Rep | Comparison between non-alcoholic fatty liver disease screening guidelines in children and adolescents. | 2019 | Details |
| A08627 | 32039370 | JHEP Rep | Quantitative digital pathology reveals association of cell-specific PNPLA3 transcription with NAFLD disease activity. | 2019 | Details |
| A08628 | 32039369 | JHEP Rep | Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease. | 2019 | Details |
| A08629 | 32039366 | JHEP Rep | Liver cancer: A leading cause of cancer death in the United States and the role of the 1945-1965 birth cohort by ethnicity. | 2019 | Details |
| A08630 | 32039365 | JHEP Rep | The burden of non-alcoholic steatohepatitis (NASH) among patients from Europe: A real-world patient-reported outcomes study. | 2019 | Details |
| A08632 | 32039349 | JHEP Rep | Liver steatosis is a strong predictor of mortality and cancer in chronic hepatitis B regardless of viral load. | 2019 | Details |
| A08633 | 32038642 | Front Immunol | The Interplay Between Tissue Niche and Macrophage Cellular Metabolism in Obesity. | 2020 | Details |
| A08634 | 32038102 | Int J Med Sci | Circulating fatty acid-binding protein 1 (FABP1) and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. | 2020 | Details |
| A08635 | 32037512 | Br J Pharmacol | P7C3-A20 alleviates fatty liver by shaping gut microbiota and inducing FGF21/FGF1, via the AMP-activated protein kinase/CREB regulated transcription coactivator 2 pathway. | 2020 | Details |
| A08636 | 32037278 | Hepatobiliary Pancreat Dis Int | Human microbiome is a diagnostic biomarker in hepatocellular carcinoma. | 2020 | Details |
| A08638 | 32036510 | Dig Dis Sci | Omega-3 Fatty Acids and Gut Microbiota: A Reciprocal Interaction in Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A08639 | 32035968 | Diabetes Metab | PNPLA3 polymorphism influences the association between high-normal TSH level and NASH in euthyroid adults with biopsy-proven NAFLD. | 2020 | Details |
| A08640 | 32035613 | Biochem Biophys Res Commun | MicroRNA-103 represses hepatic de novo lipogenesis and alleviates NAFLD via targeting FASN and SCD1. | 2020 | Details |
| A08641 | 32033865 | Trends Endocrinol Metab | Chronic Diabetes Complications: The Need to Move beyond Classical Concepts. | 2020 | Details |
| A08644 | 32033766 | Gastroenterol Clin North Am | Why Do Lifestyle Recommendations Fail in Most Patients with Nonalcoholic Fatty Liver Disease? | 2019 | Details |
| A08645 | 32033765 | Gastroenterol Clin North Am | Nutrition and Nonalcoholic Fatty Liver Disease: Current Perspectives. | 2019 | Details |